GlassScriptPhysician profile
Amy M Cooper
NPI 1962882282
$1,874.46
in general payments reported to CMS, 2019-2025
19 companies · $560 in 2025
The $560 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $204 · 2022: $265 · 2023: $535 · 2024: $310 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $728.09 | 2021-2025 | Velphoro, Velphoro, Korsuva |
| Astrazeneca Pharmaceuticals LP | $253.17 | 2023-2025 | Lokelma, Farxiga |
| Otsuka America Pharmaceutical, INC. | $210.32 | 2022-2025 | Jynarque |
| Amgen INC. | $155.20 | 2022-2024 | Tavneos |
| Ardelyx, INC. | $119.70 | 2025 | Xphozah 30 Mg |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.01 | 2021 | |
| Vifor Pharma, INC. | $76.10 | 2021-2024 | |
| Opko Pharmaceuticals, LLC | $33.53 | 2023 | Rayaldee |
| Takeda Pharmaceuticals U.S.A., INC. | $28.98 | 2023 | Gattex |
| Nxstage Medical, INC. | $25.98 | 2024 | |
| Ani Pharmaceuticals, INC. | $18.55 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $18.19 | 2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.52 | 2023 | Jardiance |
| Aurinia Pharma U.S., INC. | $16.96 | 2023 | Lupkynis |
| Daiichi Sankyo INC. | $16.50 | 2024 | Injectafer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $15.94 | 2023 | |
| Horizon Therapeutics Plc | $15.08 | 2023 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2023 | |
| Alexion Pharmaceuticals, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.